Home › Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform
 

Keywords :   


Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform

2016-03-30 06:19:04| drugdiscoveryonline Home Page

Librede, a biotechnology company specializing in yeast-based cannabinoid production, announced that it has received a Small Business Innovative Research (SBIR) grant from the National Center for Complementary & Integrative Health (NCCIH) of the National Institutes of Health (NIH)

Tags: production develop drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
More »